What Are UNH Stock Investors Betting On?
UnitedHealth (UNH) stock trades at 22.5 times its past year’s adjusted earnings, which are normalized net income with stock-based pay added back. That multiple leaves little room for error after three years of shrinking operating margins, sitting near the stock’s 10-year median despite fundamentally weaker profitability. But the price looks different against the profit expected for fiscal 2026 and fiscal 2027. So what are UnitedHealth investors betting on?
UnitedHealth Investors Are Betting On Wider Margins
UnitedHealth investors are betting on wider margins in fiscal 2026 and fiscal 2027. A P/E is the share price divided by a year of profit. On the consensus forecast for fiscal 2026, today’s price is 19.0 times earnings. On the fiscal 2027 forecast, it is 16.8 times, beside 22.5 times for the past year.
The consensus forecast has profit rising 12.9% from fiscal 2026 to fiscal 2027. Sales in the forecast rise just 3.0% over the same year. Profit only outgrows sales when a company keeps more of each dollar of sales. So the forecast P/Es are real only if UnitedHealth’s net margin widens—an expansion that ultimately depends on reversing the slide in its operating margins.
Has UnitedHealth Been Delivering Wider Margins?
Not over the last three years. Operating margin is the share of sales left after medical and running costs. At UnitedHealth, it fell each year, from 8.8% three years ago to 4.8% now.
UnitedHealth’s margins did widen in the second quarter of fiscal 2026. Operating earnings grew 55% from a year earlier on flat revenue. Management credited product and portfolio changes, and said better results in Medicare Advantage put its UnitedHealthcare business ahead of expectations. Medical costs that quarter were also flattered by $860 million in favorable reserve adjustments—mostly developed from earlier in 2026—giving a substantial one-time boost to that 55% operating jump. Management then raised its fiscal 2026 guidance for adjusted earnings per share to $19.50 to $20.
The consensus forecast of $19.95 per share for fiscal 2026 is near the top of that guidance. Management called that range the right baseline to build toward its long-term earnings growth goal of 13% to 16%. The forecast’s fiscal 2027 profit growth is at about the low end of that goal. So the forecast sits close to management’s own targets, at the upper end for fiscal 2026.
Where Could UnitedHealth’s Margin Bet Go Wrong?
Mostly in medical costs, starting with UnitedHealth’s commercial benefits business. Management said commercial costs are stubbornly high and rising above expectations. Management also moved the full recovery of commercial margins past 2027. If those costs do not ease, the consensus forecast for fiscal 2027 profit is more likely to fall than rise.
Medicare Advantage is the other major risk, despite driving the second quarter’s beat. Management said its own changes to benefits, care management and networks were a primary reason Medicare costs grew less than expected. Management added that the slower growth is not a turning point, and that Medicare costs are continuing at high levels. If Medicare cost growth speeds up again, fiscal 2027 profit could fall short of the consensus forecast.
The medical care ratio is the share of premiums UnitedHealth spends on care. Management expects it at 88.1% for fiscal 2026, plus or minus a quarter of a percentage point. UnitedHealth reports its third quarter on October 13, 2026. Management said it would probably update its Medicare cost estimate then.
If UnitedHealth’s margins recover as the forecast assumes, the P/Es on the consensus forecast are a fair picture of today’s price. Commercial medical costs are the likeliest place for that recovery to fall short. Management has already pushed back the commercial margin recovery. If those costs stay high, the stock is riskier than it looks. At current levels, you are paying for margin recovery before it has fully materialized. An upward revision to the 2026 medical care ratio in the October report would indicate that this recovery is taking longer than projected.
How To Act On UNH?
Before you decide on UNH, consider a better choice. Since its inception, the Trefis High Quality (HQ) Portfolio has beaten the benchmark that combines the three major indices – the S&P 500, S&P Mid-cap, and Russell 2000. And it did so without taking the concentrated risk that comes with retail stock picking.
If you’d rather act on UNH itself:
| Play Offense | Play Defense |
|---|---|
| Learn More About UNH & Invest | Save Taxes On Capital Gain |
| Earn From UNH Cash Secured Puts | Covered Call Against UNH |